DOI:
10.1055/s-00000059
Pneumologie
LinksClose Window
References
Aspler A, Long R, Trajman A. et al.
Impact of treatment completion, intolerance and adverse events on health system costs in a randomised trial of 4 months rifampin or 9 months isoniazid for latent TB.
Thorax 2010;
65: 582-587
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.